Chemical Strategies To Target Bacterial Virulence.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Chemical Reviews

• Publication date

  2017-02-24

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.chemrev.6b00676PMID 28234447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Shigellosis

  2019cited by this paper
• Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo Assays.

  2017cited by this paper
• Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study.

  2016cited by this paper
• Plant Natural Products Targeting Bacterial Virulence Factors.

  2016cited by this paper
• Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011.

  2016cited by this paper
• Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.

  2016cited by this paper
• Investigation of Escherichia coli Harboring the mcr-1 Resistance Gene - Connecticut, 2016.

  2016cited by this paper
• Tackling drug-resistant infections globally: final report and recommendations

  2016cited by this paper
• Detection of mcr-1 among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015

  2016cited by this paper
• Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States

  2016cited by this paper
• Clostridium difficile infection

  2016cited by this paper
• Escherichia coli Harboring mcr-1 and blaCTX-M on a Novel IncF Plasmid: First Report of mcr-1 in the United States

  2016cited by this paper
• A small-molecule antivirulence agent for treating Clostridium difficile infection

  2015cited by this paper
• Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.

  2015cited by this paper
• Control of brain development, function, and behavior by the microbiome.

  2015cited by this paper
• Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.

  2015cited by this paper
• Novel enzymatic synthesis of spacer-linked P(k) trisaccharide targeting for neutralization of Shiga toxin.

  2015cited by this paper
• Burden of Clostridium difficile infection in the United States.

  2015cited by this paper
• Novel actions of 2-deoxy-D-glucose: protection against Shiga toxins and changes in cellular lipids.

  2015cited by this paper
• Multifunctional-autoprocessing repeats-in-toxin (MARTX) Toxins of Vibrios

  2015cited by this paper
• Synthesis, Chiral Separation, Absolute Configuration Assignment, and Biological Activity of Enantiomers of Retro‐1 as Potent Inhibitors of Shiga Toxin

  2015cited by this paper
• Epitope targeting of tertiary protein structure enables target-guided synthesis of a potent in-cell inhibitor of botulinum neurotoxin.

  2015cited by this paper
• Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A.

  2015cited by this paper
• Suppression of Virulence of Toxigenic Vibrio cholerae by Anethole through the Cyclic AMP (cAMP)-cAMP Receptor Protein Signaling System

  2015cited by this paper
• Small molecule inhibitors of Clostridium difficile toxin B-induced cellular damage.

  2015cited by this paper
• Clostridium difficile infection.

  2015cited by this paper
• Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.

  2015cited by this paper
• Ligand‐induced expansion of the S1′ site in the anthrax toxin lethal factor

  2015cited by this paper
• New natural products as new leads for antibacterial drug discovery.

  2014cited by this paper
• Critical Roles of Clostridium difficile Toxin B Enzymatic Activities in Pathogenesis

  2014cited by this paper
• Identification of Clinically Viable Quinolinol Inhibitors of Botulinum Neurotoxin A Light Chain

  2014cited by this paper
• Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain.

  2014cited by this paper
• Small molecule inhibitors of anthrax lethal factor toxin.

  2014cited by this paper
• Discovery of inhibitors of Shiga toxin type 2 by on-plate generation and screening of a focused compound library.

  2014cited by this paper
• Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.

  2014cited by this paper
• New Therapeutic Developments against Shiga Toxin-Producing Escherichia coli

  2014cited by this paper
• Benzoquinones as inhibitors of botulinum neurotoxin serotype A.

  2014cited by this paper
• Anthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand binding.

  2014cited by this paper
• Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography

  2014cited by this paper
• Multistate point-prevalence survey of health care-associated infections.

  2014cited by this paper
• Small-Molecule Inhibitors of Lethal Factor Protease Activity Protect against Anthrax Infection

  2013cited by this paper
• Long-term outcomes of Shiga toxin hemolytic uremic syndrome

  2013cited by this paper
• Clostridium difficile toxin B-induced necrosis is mediated by the host epithelial cell NADPH oxidase complex

  2013cited by this paper
• Small-Molecule Inhibitors of toxT Expression in Vibrio cholerae

  2013cited by this paper
• Identification of novel host-targeted compounds that protect from anthrax lethal toxin-induced cell death.

  2013cited by this paper
• Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers

  2013cited by this paper
• Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.

  2013cited by this paper
• Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: synthesis, crystallography, modeling, kinetic and cellular based studies.

  2013cited by this paper
• Identification of a Peptide-Based Neutralizer That Potently Inhibits Both Shiga Toxins 1 and 2 by Targeting Specific Receptor-Binding Regions

  2013cited by this paper
• Poly(N-vinyl-2-pyrrolidone-co-vinyl alcohol), a versatile amphiphilic polymeric scaffold for multivalent probes.

  2013cited by this paper
• Targeting bacterial toxins.

  2012cited by this paper
• Clostridium difficile Toxin B Causes Epithelial Cell Necrosis through an Autoprocessing-Independent Mechanism

  2012cited by this paper
• Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A.

  2012cited by this paper
• Inhibitors of the Cellular Trafficking of Ricin

  2012cited by this paper
• Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.

  2012cited by this paper
• Models for the study of Clostridium difficile infection

  2012cited by this paper
• Chemical Structure of Retro-2, a Compound That Protects Cells against Ribosome-Inactivating Proteins

  2012cited by this paper
• The global burden of cholera.

  2012cited by this paper
• D-proline-based peptidomimetic inhibitors of anthrax lethal factor.

  2012cited by this paper
• The human microbiome: at the interface of health and disease

  2012cited by this paper
• Can we identify patients at high risk of recurrent Clostridium difficile infection?

  2012cited by this paper
• Clostridium difficile Toxins: Mediators of Inflammation

  2012cited by this paper
• Synthesis and assessment of globotriose-chitosan conjugate, a novel inhibitor of shiga toxins produced by Escherichia coli.

  2012cited by this paper
• Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.

  2012cited by this paper
• Structural Framework for Covalent Inhibition of Clostridium botulinum Neurotoxin A by Targeting Cys165*

  2012cited by this paper
• Enhancing the Pharmacokinetic Properties of Botulinum Neurotoxin Serotype A Protease Inhibitors Through Rational Design.

  2011cited by this paper
• Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide

  2011cited by this paper
• Inhibition of virulence potential of Vibrio cholerae by natural compounds

  2011cited by this paper
• Foodborne Illness Acquired in the United States—Major Pathogens

  2011cited by this paper
• Structural characterization of three novel hydroxamate-based zinc chelating inhibitors of the Clostridium botulinum serotype A neurotoxin light chain metalloprotease reveals a compact binding site resulting from 60/70 loop flexibility.

  2011cited by this paper
• Novel classes of antibiotics or more of the same?

  2011cited by this paper
• Modeling the mechanism of the glutathione peroxidase mimic ebselen.

  2011cited by this paper
• Antidotes to anthrax lethal factor intoxication. Part 2: structural modifications leading to improved in vivo efficacy.

  2011cited by this paper
• Synthesis and evaluation of library of betulin derivatives against the botulinum neurotoxin A protease.

  2011cited by this paper
• Structure-Based Design of Ricin Inhibitors

  2011cited by this paper
• Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.

  2011cited by this paper
• Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A

  2011cited by this paper
• Carbapenems: Past, Present, and Future

  2011cited by this paper
• Notice of CDC's discontinuation of investigational pentavalent (ABCDE) botulinum toxoid vaccine for workers at risk for occupational exposure to botulinum toxins.

  2011cited by this paper
• Post-Intoxication Inhibition of Botulinum Neurotoxin Serotype A within Neurons by Small-Molecule, Non-Peptidic Inhibitors

  2011cited by this paper
• Iterative Structure-Based Peptide-Like Inhibitor Design against the Botulinum Neurotoxin Serotype A

  2010cited by this paper
• Synthesis and affinity evaluation of a small library of bidentate cholera toxin ligands: towards nonhydrolyzable ganglioside mimics.

  2010cited by this paper
• Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins

  2010cited by this paper
• Capsaicin, a potential inhibitor of cholera toxin production in Vibrio cholerae.

  2010cited by this paper
• Botulinum neurotoxin A protease: discovery of natural product exosite inhibitors.

  2010cited by this paper
• Antidotes to anthrax lethal factor intoxication. Part 1: Discovery of potent lethal factor inhibitors with in vivo efficacy.

  2010cited by this paper
• Testing Nucleoside Analogues as Inhibitors of Bacillus anthracis Spore Germination In Vitro and in Macrophage Cell Culture

  2010cited by this paper
• Inhibition of retrograde transport protects mice from lethal ricin challenge.

  2010cited by this paper
• Anti-virulence strategies to combat bacteria-mediated disease

  2010cited by this paper
• Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidase.

  2010cited by this paper
• Rational design of inhibitors and activity-based probes targeting Clostridium difficile virulence factor TcdB.

  2010cited by this paper
• Pharmacophore Refinement Guides the Rational Design of Nanomolar-Range Inhibitors of the Botulinum Neurotoxin Serotype A Metalloprotease.

  2010cited by this paper
• Identification of a Natural Product Antagonist against the Botulinum Neurotoxin Light Chain Protease.

  2010cited by this paper
• Peptide inhibitors targeting Clostridium difficile toxins A and B.

  2010cited by this paper
• Pharmacophore refinement guides the design of nanomolar-range botulinum neurotoxin serotype a light chain inhibitors

  2010cited by this paper
• Treatment with monoclonal antibodies against Clostridium difficile toxins.

  2010cited by this paper
• Identification of small-molecule inhibitors of ricin and shiga toxin using a cell-based high-throughput screen.

  2010cited by this paper
• Prevention of Clostridium sordellii lethal toxin-induced apoptotic cell death by tauroursodeoxycholic acid.

  2009cited by this paper
• Development of Ebselen, a Glutathione Peroxidase Mimic, for the Prevention and Treatment of Noise-Induced Hearing Loss

  2009cited by this paper
• Mechanistic and structural insights into the proteolytic activation of Vibrio cholera MARTX toxin

  2009cited by this paper

• Suppressed Virulence and Enhanced Antibiotic Efficacy of Madecassic Acid as a Potent Quorum Sensing Inhibitor against Klebsiella pneumoniae.

  2026cites this paper
• Exploiting Pharmacokinetic/Pharmacodynamic Methods for Optimizing and Accelerating Drug Development of Innovative Anti‐Infectives

  2026cites this paper
• A comprehensive review on transition-metal-catalyzed C H functionalization: Mechanisms, selectivity, and synthetic applications

  2026cites this paper
• Synthesis of alduronic acid lactones and rare sugar glyconolactones via decarboxylative oxygenation of uronic acids: construction of polyhydroxylated fused-ring alkaloids

  2025cites this paper
• Surface-Enhanced Raman Spectroscopy and Multivariate Analysis for Elucidating Mechanisms of Action in Antibacterial Agents.

  2025cites this paper
• Synthesis and antibacterial applications of Gemini-QA N-chloramines with rigid spacer

  2025cites this paper
• Design and Synthesis of Novel Coumarin-Piperazine Derivatives as Potential Antimicrobial Agents

  2025cites this paper
• Antibiotic-Resistant Salmonella in Animal Products Jeopardize Human Health

  2025cites this paper
• Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of Clostridium botulinum and Bacillus anthracis

  2024cites this paper
• Antimicrobial Strategies Proposed for the Treatment of S. pseudintermedius and Other Dermato-Pathogenic Staphylococcus spp. in Companion Animals: A Narrative Review

  2024cites this paper
• Synthesis of Gemini-Quaternary Ammonium N-Chloramine Biocides for Antibacterial Applications

  2024cites this paper
• Evaluating virulence features of Acinetobacter baumannii resistant to polymyxin B.

  2024cites this paper
• Application of inhibitors targeting the type III secretion system in phytopathogenic bacteria

  2024cites this paper
• Discovery of Antibacterial Compounds against Xanthomonas citri subsp. citri from a Marine Fungus Aspergillus terreus SCSIO 41202 and the Mode of Action.

  2024cites this paper
• Pore-Forming Toxin-Driven Recovery of Peroxidase-Mimicking Activity in Biomass Channels for Label-Free Electrochemical Bacteria Sensing.

  2024cites this paper
• Catalytic Nanoparticles in Biomedical Applications: Exploiting Advanced Nanozymes for Therapeutics and Diagnostics

  2024cites this paper
• Rational design of hemocompatible hydrogel microspheres towards pathogen-associated molecular patterns removal for Gram-positive bacteria-induced sepsis

  2024cites this paper
• Review of Light-Activated Antimicrobial Nanoparticle–Polymer Composites for Biomedical Devices

  2024cites this paper
• A hydrogen-bonded curdlan-chitosan/polyvinyl alcohol edible dual functional hydrogel bandage against MRSA promotes wound healing.

  2024cites this paper
• Vibrio cholerae virulence and its suppression through the quorum-sensing system

  2024cites this paper
• Mechanism-guided strategies for combating antibiotic resistance

  2024cites this paper
• Electrically polarized nanoscale surfaces generate reactive oxygenated and chlorinated species for deactivation of microorganisms

  2024cites this paper
• Compounds Derived from 5‐Fluoropyridine and Benzo[b]thiophene: Killing Mycobacterium tuberculosis and Reducing its Virulence

  2024cites this paper
• Sugar-Coated: Can Multivalent Glycoconjugates Improve upon Nature’s Design?

  2024cites this paper
• A Review of Antibacterial Candidates with New Modes of Action

  2024cites this paper
• Pillar[5]arene stabilized gold nanoparticles for the enhanced light-triggered nitric oxide release with antibacterial and antibiofilm activities

  2024cites this paper
• Chemical dissection of bacterial virulence.

  2024cites this paper
• Molecular mechanism of green tea polyphenol epicatechin gallate attenuating Staphylococcus aureus pathogenicity by targeting Ser/Thr phosphatase Stp1.

  2023cites this paper
• Plant‐derived virulence arresting drugs as novel antimicrobial agents: Discovery, perspective, and challenges in clinical use

  2023cites this paper
• Phospholipid membrane-protected photoelectrochemical chip: A specific test-to-treat platform for bacteria secreting pore-forming toxins with phosphatidylcholine receptor

  2023cites this paper
• Ag+-Adsorbing Semiconducting Polymer Nanosponge for Smart Local Treatment of Wound Infection.

  2023cites this paper
• Processes of Synthesis and Characterization of Silver Nanoparticles with Antimicrobial Action and their Future Prospective

  2023cites this paper
• Coupling a Virulence-Targeting Moiety with Ru-Based AMP Mimics Efficiently Improved Its Anti-Infective Potency and Therapeutic Index.

  2023cites this paper
• Anti-Vibrio parahaemolyticus compounds from Streptomyces parvus based on Pan-genome and subtractive proteomics

  2023cites this paper
• Cell-membrane-coated nanoparticles for the fight against pathogenic bacteria, toxins, and inflammatory cytokines associated with sepsis

  2023cites this paper
• Cellular membrane-targeting ruthenium complexes as efficient photosensitizers for broad-spectrum antibacterial activity.

  2023cites this paper
• Selective killing of the human gastric pathogen Helicobacter pylori by mitochondrial respiratory complex I inhibitors.

  2023cites this paper
• Antibacterial Potentiality of Isatin-Containing Hybrid Derivatives

  2023cites this paper
• AIEgen-Based Nanomaterials for Bacterial Imaging and Antimicrobial Applications: Recent Advances and Perspectives

  2023cites this paper
• Isoflavone glucoside genistin, an inhibitor targeting Sortase A and Listeriolysin O, attenuates the virulence of Listeria monocytogenes in vivo and in vitro.

  2023cites this paper
• Inhibition of the sea Gene Expression in Staphylococcus aureus Using the Aqueous and Alcoholic Extracts of the Grapevine (Vitis vinifera L.) Seeds.

  2022cites this paper
• In Situ Structure Transformation of a Sprayed Gel for pH‐Ultrasensitive Nano‐Catalytic Antibacterial Therapy

  2022cites this paper
• Moxifloxacin embedded p-Sulfonatocalix[6]arene: Multispectroscopic studies to evaluate its cytotoxicity, antibacterial efficacy, and molecular docking

  2022cites this paper
• Synthesis and antibiofilm evaluation of N-acyl-2-aminopyrimidine derivatives against Acinetobacter baumannii.

  2022cites this paper
• Hyperglycemia in Diabetic Skin Infections Promotes Staphylococcus aureus Virulence Factor Aureolysin: Visualization by Molecular Imaging.

  2022cites this paper
• Bacterial AB toxins and host-microbe interactions.

  2022cites this paper
• From Plasma Membrane to Mitochondria: Time-Dependent Photodynamic Antibacterial and Anticancer Therapy with a Near-Infrared AIE-Active Photosensitizer

  2022cites this paper
• Progress and prospects of nanomaterials against resistant bacteria.

  2022cites this paper
• An insilico study of selected mannose derivatives against UropathogenicEscherichia colitargeting fimH adhesin protein

  2022cites this paper
• N-acylhomoserine lactonase-based hybrid nanoflowers: a novel and practical strategy to control plant bacterial diseases

  2022cites this paper
• Investigation of Salicylanilides as Botulinum Toxin Antagonists.

  2022cites this paper
• Secondary Ammonium-Based Hyperbranched Poly(amidoamine) with Excellent Membrane-Active Property for Multidrug-Resistant Bacterial Infection.

  2022cites this paper
• An In-silico Study Showing Potentials of Selected Anthocyanin Derivatives against Uropathogenic E. coli Adhesin Protein

  2022cites this paper
• Computational approach confirming the therapeutic potential of selected mannose derivatives against fimH of Uropathogenic E. coli

  2022cites this paper
• Metformin capped Cu2(OH)3Cl nanosheets for chemodynamic wound disinfection

  2022cites this paper
• Fluorescent dyes with multiple quaternary ammonium centers for specific image discrimination and Gram-positive antibacterial activity.

  2022cites this paper
• Polyphenol-driving assembly for constructing chitin-polyphenol-metal hydrogel as wound dressing.

  2022cites this paper
• Combatting Antibiotic Resistance Using Supramolecular Assemblies

  2022cites this paper
• The antibacterial activity of quinazoline and quinazolinone hybrids.

  2022cites this paper
• Versatile polymer-based strategies for antibacterial drug delivery systems and antibacterial coatings.

  2022cites this paper
• Amino Acid-Functionalized MoS2 Quantum Dots for Selective Antibacterial Activity

  2021cites this paper
• Thioether-linked dihydropyrrol-2-one analogues as PqsR antagonists against antibiotic resistant Pseudomonas aeruginosa.

  2021cites this paper
• Exploring the future of infectious disease treatment in a post-antibiotic era: A comparative review of alternative therapeutics.

  2021cites this paper
• Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant.

  2021cites this paper
• Polymeric Nanoparticles for Antimicrobial Therapies: An up-to-date Overview

  2021cites this paper
• Effective Antibacterial and Antihemolysin Activities of Ellipticine Hydrochloride against Streptococcus suis in a Mouse Model

  2021cites this paper
• Nanomaterial-based strategies in antimicrobial applications: Progress and perspectives

  2021cites this paper
• Antivirulence Properties of a Low-Molecular-Weight Quaternized Chitosan Derivative against Pseudomonas aeruginosa

  2021cites this paper
• Multi-Enzyme-Synergetic ultrathin protein nanosheets display high efficient and switch on/off antibacterial activities

  2021cites this paper
• Combating antibiotic resistance: current strategies for the discovery of novel antibacterial materials based on macrocycle supramolecular chemistry

  2021cites this paper
• Graphdiyne–hemin-mediated catalytic system for wound disinfection and accelerated wound healing

  2021cites this paper
• Enzyme-like antibacterial activities of Cu9S5 nanoflowers with vacancy-type dependence

  2021cites this paper
• Visible-light-promoted late-stage direct fluoroalkylation of nitroimidazoles

  2021cites this paper
• Anti-virulence Therapy against Bacterial Infections: Mechanisms of Action and Challenges

  2021cites this paper
• Multicharged Supramolecular Assembly Mediated by Polycationic Cyclodextrin for Efficiently Photodynamic Antibacteria.

  2021cites this paper
• Bacterial virulence factors: a target for heterocyclic compounds to combat bacterial resistance

  2021cites this paper
• Natural Berberine-derived Azolyl Ethanols as New Structural Antibacterial Agents against Drug-Resistant Escherichia coli.

  2021cites this paper
• Control strategies for heterogeneous plant 1 pathogens : evolutionary and agricultural 2 consequences

  2021cites this paper
• Does targeting Arg98 of FimH lead to high affinity antagonists?

  2020cites this paper
• Identification of novel therapeutic target and epitopes through proteome mining from essential hypothetical proteins in Salmonella strains: An In silico approach towards antivirulence therapy and vaccine development.

  2020cites this paper
• Smart nanoprobe based on two-photon sensitized terbium-carbon dots for dual-mode fluorescence thermometer and antibacterial

  2020cites this paper
• Bacterial Resistance: antibiotics of last generation used in clinical practice and the arise of natural products as new therapeutic alternatives.

  2020cites this paper
• In silico Drug Target Discovery Through Proteome Mining from M. tuberculosis: An Insight towards Antivirulent Therapy.

  2020cites this paper
• Structural characterization of LsrK to target quorum sensing and comparison between X-ray and homology model

  2020cites this paper
• Antibiotics can be used to contain drug-resistant bacteria by maintaining sufficiently large sensitive populations

  2020cites this paper
• Supramolecular Polymeric Radicals: Highly Promoted Formation and Stabilization of Naphthalenediimide Radical Anions.

  2020cites this paper
• Target-Based Design of Promysalin Analogues Identifies a New Putative Binding Cleft in Succinate Dehydrogenase.

  2020cites this paper
• Synergistic chemotherapy, physiotherapy and photothermal therapy against bacterial and biofilms infections through construction of chiral glutamic acid functionalized gold nanobipyramids

  2020cites this paper
• Indole/isatin‐containing hybrids as potential antibacterial agents

  2020cites this paper
• Using In Vivo Assessment on Host Defense Peptide Mimicking Polymer-Modified Surfaces for Combating Implant Infections.

  2020cites this paper
• Study on Degradation of Azithromycin Antibiotics by Molybdenum Sulfide Graphene Oxide Composites under Visible Light

  2020cites this paper
• Uncariitannin, a polyphenolic polymer from Uncaria gambier, attenuates Staphylococcus aureus virulence through an MgrA-mediated regulation of α-hemolysin.

  2019cites this paper
• Synthesis of BiVO4/WO3 composite film for highly efficient visible light induced photoelectrocatalytic oxidation of norfloxacin

  2019cites this paper
• Antibacterial supramolecular polymers constructed via self-sorting: promoting antibacterial performance and controllable degradation

  2019cites this paper
• Reactive Oxygen Species (ROS)-Based Nanomedicine.

  2019cites this paper
• A 'catch-and-release' receptor for the cholera toxin.

  2019cites this paper
• Benzofuran-isatin-imine hybrids tethered via different length alkyl linkers: Design, synthesis and in vitro evaluation of anti-tubercular and anti-bacterial activities as well as cytotoxicity.

  2019cites this paper
• Isolation of 11,12- seco-Rifamycin W Derivatives Reveals a Cleavage Pattern of the Rifamycin Ansa Chain.

  2019cites this paper
• The inhibitory mechanism of aurintricarboxylic acid targeting serine/threonine phosphatase Stp1 in Staphylococcus aureus: insights from molecular dynamics simulations

  2019cites this paper
• Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections

  2019cites this paper